Paper25752337
Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease.
Aubert L and 5 others. J Am Geriatr Soc, 2015. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease. Papers, record 25752337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25752337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cognition Disorders | Major topic |
| Aged | |
| Aged, 80 and over | |
| Cohort Studies | |
| Cost of Illness | |
| Disease Progression | |
| Female | |
| Humans | |
| Male | |
| Retrospective Studies | |
| Severity of Illness Index | |
| Time Factors |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42746321 | Neuropsychiatric symptoms and gait/balance are predictors of functional trajectories in dementias. | Dement Neuropsychol | 2026 | https://conductscience.org/library/papers/42746321 | PubMed |
| 40688757 | Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease. | Biomark Neuropsychiatry | 2025 | https://conductscience.org/library/papers/40688757 | PubMed |
| 40522060 | Non-amnestic initial symptoms may be less prevalent in African American than White participants with Alzheimer's and mixed Lewy body and Alzheimer's pathology. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40522060 | PubMed |
| 40240995 | Association between comorbidity indices and nursing home admission in patients with Alzheimer's disease: a longitudinal observational study using the MEMORA cohort. | BMC Geriatr | 2025 | https://conductscience.org/library/papers/40240995 | PubMed |
| 39859258 | Associations Between Diabetes Mellitus and Neurodegenerative Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859258 | PubMed |
| 38962384 | New and emerging drug therapies for Alzheimer disease. | Aust Prescr | 2024 | https://conductscience.org/library/papers/38962384 | PubMed |
| 38071284 | Dementia subtypes, cognitive decline and survival among older adults attending a memory clinic in Cape Town, South Africa: a retrospective study. | BMC Geriatr | 2023 | https://conductscience.org/library/papers/38071284 | PubMed |
| 36902829 | The Influence of Healthy Habits on Cognitive Functions in a Group of Hemodialysis Patients. | J Clin Med | 2023 | https://conductscience.org/library/papers/36902829 | PubMed |
| 36430365 | Recent Progress in Research on Mechanisms of Action of Natural Products against Alzheimer's Disease: Dietary Plant Polyphenols. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430365 | PubMed |
| 36187908 | Conceptualising comorbidity and multimorbidity in dementia: A scoping review and syndemic framework. | J Multimorb Comorb | 2022 | https://conductscience.org/library/papers/36187908 | PubMed |
| 35888143 | Dementia and Risk Factors: Results from a Prospective, Population-Based Cohort Study. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35888143 | PubMed |
| 34489627 | Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus. | Front Neurosci | 2021 | https://conductscience.org/library/papers/34489627 | PubMed |
| 34329447 | Disease Burden Affects Aging Brain Function. | J Gerontol A Biol Sci Med Sci | 2022 | https://conductscience.org/library/papers/34329447 | PubMed |
| 34079471 | Thioredoxin-1 Is a Target to Attenuate Alzheimer-Like Pathology in Diabetic Encephalopathy by Alleviating Endoplasmic Reticulum Stress and Oxidative Stress. | Front Physiol | 2021 | https://conductscience.org/library/papers/34079471 | PubMed |
| 34069890 | Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. | Cells | 2021 | https://conductscience.org/library/papers/34069890 | PubMed |
| 33527720 | Generalizability of findings from a clinical sample to a community-based sample: A comparison of ADNI and ARIC. | Alzheimers Dement | 2021 | https://conductscience.org/library/papers/33527720 | PubMed |
| 33050345 | The Dual Role of Glutamatergic Neurotransmission in Alzheimer's Disease: From Pathophysiology to Pharmacotherapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33050345 | PubMed |
| 32083135 | Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease. | J Diabetes Res | 2020 | https://conductscience.org/library/papers/32083135 | PubMed |
| 30029715 | Multiple chronic conditions: Implications for cognition - Findings from the Wisconsin Registry for Alzheimer's Prevention (WRAP). | Appl Nurs Res | 2018 | https://conductscience.org/library/papers/30029715 | PubMed |
| 29966195 | Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts. | J Alzheimers Dis | 2018 | https://conductscience.org/library/papers/29966195 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25752337
GET https://conductscience.org/api/papers/v1/25752337/cited_by?page=2